Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
05/2012
05/01/2012US8168186 Therapeutic using a bispecific antibody
05/01/2012US8168184 Bi-specific monoclonal antibody (specific for both CD3 and CD11B) therapeutic drug
05/01/2012US8168159 Compounds for tumor diagnosis and therapy
04/2012
04/26/2012WO2011155805A3 Radioisotope labeled folic acid conjugate human serum albumin specific to tumor and sentinel lymph node
04/26/2012US20120101055 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
04/26/2012US20120100073 Pet radiotracers for imaging fatty acid metabolism and storage
04/26/2012US20120100072 Pet imaging of fibrogenesis
04/26/2012US20120100071 Synthesis and use of radiolabelled insulin analogues
04/26/2012US20120100070 Cyclic Peptide Analogues For Non-Invasive Imaging of Pancreatic Beta-Cells
04/26/2012US20120100069 B-Lymphocyte Targeting Agents for Use in a Method for the Treatment of a Disease
04/26/2012US20120100068 Anti-CD74 Immunoconjugates and Methods of Use
04/26/2012US20120100067 Solubilisation Method
04/25/2012EP2444800A2 A direct solid sample analytical technology for determining a content and a uniformity thereof in a lyophilized kit of a sulfur-containing chelator with a stable complex capacity for radiotechnetium (Tc-99m) and radiorhenium (Re-186, Re-188)
04/25/2012EP2444106A1 Method and system for concentrating radioactive technetium as raw material for radioactive drug and labeling compound therefor and collecting the same by elution
04/25/2012EP1112084B2 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
04/25/2012CN102423507A 一种放射性核素标记的载药生物高分子纳米纤维膜、制备方法及其用途 Drug biopolymer radionuclide labeled nanofiber membrane preparation method and use thereof
04/25/2012CN101653614B 一类亲骨性<sup>99m</sup>Tc配合物及其制备和应用 A class of pro-bony <sup> 99m </ sup> Tc complexes and their preparation and application
04/25/2012CN101180272B Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
04/24/2012US8163928 Heteroaryl substituted benzothiazoles
04/24/2012US8163725 Gel compositions and methods of use
04/24/2012US8163701 Prodrugs of active agents
04/24/2012US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery
04/24/2012US8163269 Bioactive stents for type II diabetics and methods for use thereof
04/24/2012CA2501757C Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
04/24/2012CA2478305C Technetium-dipyridine complexes, and methods of use thereof
04/19/2012WO2012051170A2 Imaging of meningiomas using phingylbenzothiazole, stilbene, or biphenylalkyne derivatives
04/19/2012WO2012049624A1 Pretargeting kit, method and agents used therein
04/19/2012WO2012024519A3 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
04/19/2012WO2012000791A3 Diagnostic for localizing a diseased tissue
04/19/2012WO2011159789A3 Tritiated planar carbon forms
04/19/2012WO2011133216A3 Mutant nis protein and uses thereof
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095324 Method for a nuclear medicine examination
04/19/2012US20120095235 Thioflavin derivates for use in the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
04/19/2012US20120093727 Compositions and methods for in vivo imaging of myelin in the peripheral nervous system
04/19/2012US20120093726 Radiolabeled Fluorine Derivatives of Methionine
04/19/2012US20120093725 Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies
04/19/2012US20120093724 Methods and compositions for the detection of cancer
04/19/2012US20120093723 Nanocarrier compositions and methods
04/19/2012US20120093722 Synthetic diblock copolypeptide hydrogels for use in the central nervous system
04/19/2012US20120093721 Uses of cancer-targeting peptides in cancer diagnosis
04/19/2012US20120093720 Molecularly Imprinted Polymers for Use as Imaging and Therapeutics Agents
04/19/2012US20120093719 Antibodies against prostate specific membrane antigen
04/19/2012US20120093718 Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
04/19/2012US20120093717 Microsphere/nanofiber composites for delivery of drugs, growth factors, and other agents
04/19/2012US20120093716 Use of antisecretory factors (af) for optimizing cellular uptake
04/19/2012US20120090604 Synthesis of small particles
04/19/2012DE102010042517A1 Verbessertes SPECT-Verfahren Improved SPECT method
04/19/2012DE102010042506A1 Nuclear medicine examination of a patient comprises e.g. creating a magnetic resonance imaging of an examination region of the patient after administering magnetic resonance contrast agent to patient
04/18/2012EP2441474A1 Methods and compositions for modulating adipocyte function
04/18/2012EP2440254A2 Pet imaging of fibrogenesis
04/18/2012EP2440253A2 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells
04/18/2012CN102421454A 用于显像脂肪酸代谢和存储的pet放射性示踪剂 Pet radiotracers for imaging of fatty acid metabolism and storage
04/17/2012US8158649 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
04/17/2012US8158580 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
04/17/2012US8158573 Therapeutic and diagnostic conjugates for use with multispecific antibodies
04/17/2012US8158106 Drug delivery; microparticles immobilized on polymer surface
04/12/2012WO2012047354A2 Environmentally sensitive compositions
04/12/2012WO2012047317A2 Tumor specific antibodies and uses therefor
04/12/2012WO2011060887A3 Method for production of f-18 labeled glutamic acid derivatives
04/12/2012US20120088751 Pharmaceutical compounds
04/12/2012US20120087909 Neutralizing monoclonal antibodies to respiratory syncytial virus
04/12/2012US20120087863 Peptide Derivative and Use of the Same
04/12/2012US20120087861 Human Anti-Tau Antibodies
04/12/2012US20120087860 Methods for in vivo cancer detection, diagnosis and therapy using multidomain biotags
04/12/2012US20120087859 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
04/12/2012US20120087858 Dual variable domain immunoglobulins and uses thereof
04/12/2012US20120087857 Gadolinium expressed lipid nanoparticles for magnetic resonance imaging
04/12/2012CA2814040A1 A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use
04/12/2012CA2813814A1 Tumor specific antibodies and uses therefor
04/12/2012CA2805387A1 Environmentally sensitive compositions
04/11/2012EP2439747A2 68 Ga generator
04/11/2012EP2438918A1 Benzimidazole-derived compounds used as markers in the case of neurodegenerative diseases
04/11/2012EP2438085A1 Synthesis and use of radiolabelled insulin analogues
04/11/2012EP2437790A1 Conjugation methods
04/11/2012EP2437727A2 Peptides for transport of therapeutics and their carriers in mouse models and humans
04/11/2012EP2437653A1 Paa nanoparticles for enhancement of tumor imaging
04/11/2012CN102413844A 标记的分子成像剂、制备方法及使用方法 Labeled molecular imaging agents, methods for preparing and methods of use
04/11/2012CN102406952A <sup>11</sup>C-碳酸氢盐注射液在制备酸碱失衡PET药物中的应用 <Sup> 11 </ sup> C- bicarbonate injection in the preparation of acid-base balance in the application of PET drugs
04/11/2012CN102406944A 抗ku70内化的抗体 Within the anti-ku70 antibodies
04/10/2012US8153600 Enhancing non-denatured collagenous tissues to increase resistance to tearing, fissuring, rupturing, and/or delamination via genipin crosslinking treatment; improving fatigue resistance
04/10/2012US8153593 Transglutaminase inhibitors and methods of use thereof
04/10/2012US8153582 Personal-care articles having self-assembling peptides
04/10/2012US8153581 Process for producing an injectable medicament preparation
04/10/2012US8153126 Anti-αvβ6 antibodies
04/10/2012US8153101 Methods and compositions for F-18 labeling of proteins, peptides and other molecules
04/10/2012US8153100 Methods and compositions for F-18 labeling of proteins, peptides and other molecules
04/05/2012WO2012041953A1 In vivo imaging method for cancer
04/05/2012WO2012041862A1 Apoptosis imaging agents based on lantibiotic peptides
04/05/2012WO2012040824A1 Anti-ceacam6 antibodies and uses thereof
04/05/2012WO2012009080A3 Device for radiation-activated localized delivery of treatment agents
04/05/2012WO2011143514A3 Nanogenerator
04/05/2012US20120082619 Labelled adrenomedullin derivatives and their use for imaging and therapy
04/05/2012US20120082618 Prostate cancer diagnosis and treatment
04/05/2012US20120082616 Aptamer Conjugates for Targeting of Therapeutic and/or Diagnostic Nanocarriers
04/05/2012CA2813133A1 Anti-ceacam6 antibodies and uses thereof
04/05/2012CA2810573A1 Apoptosis imaging agents based on lantibiotic peptides
04/05/2012CA2808324A1 In vivo imaging method for cancer
04/05/2012CA2749505A1 68ga generator
04/04/2012EP2436410A1 Container with constrained quality maintenance agent
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 243